Efficacy and safety of initial combination therapy with sitagliptin and metformin in patients with type 2 diabetes: a 54-week study.

Abstract

OBJECTIVE To assess the 54-week efficacy and safety of initial combination therapy with sitagliptin and metformin in patients with type 2 diabetes and inadequate glycemic control (HbA(1c) 7.5-11%) on diet and exercise. METHODS AND MATERIALS This was multinational study conducted at 140 clinical sites in 18 countries. Following an initial 24-week, double… (More)
DOI: 10.1185/03007990802705679

Topics

Cite this paper

@article{WilliamsHerman2009EfficacyAS, title={Efficacy and safety of initial combination therapy with sitagliptin and metformin in patients with type 2 diabetes: a 54-week study.}, author={Debora E. Williams-Herman and Jeremy Johnson and Rujun Teng and Edmund Luo and Michael J Davies and Keith D. Kaufman and Barry J. Goldstein and John M. Amatruda}, journal={Current medical research and opinion}, year={2009}, volume={25 3}, pages={569-83} }